4017 Stock Overview
Dr. Soliman Abdel Kader Fakeeh Hospital Company establishes, operates, and manages hospitals, clinics, medical, educational, and training centers in the Kingdom of Saudi Arabia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 4017 from our risk checks.
Dr. Soliman Abdel Kader Fakeeh Hospital Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س58.90 |
| 52 Week High | ر.س66.70 |
| 52 Week Low | ر.س54.50 |
| Beta | 0 |
| 11 Month Change | 0.17% |
| 3 Month Change | -1.34% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -6.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4017 | SA Healthcare | SA Market | |
|---|---|---|---|
| 7D | -0.2% | -1.5% | -0.04% |
| 1Y | n/a | -2.4% | -9.2% |
Return vs Industry: Insufficient data to determine how 4017 performed against the SA Healthcare industry.
Return vs Market: Insufficient data to determine how 4017 performed against the SA Market.
Price Volatility
| 4017 volatility | |
|---|---|
| 4017 Average Weekly Movement | 2.3% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in SA Market | 7.5% |
| 10% least volatile stocks in SA Market | 2.6% |
Stable Share Price: 4017 has not had significant price volatility in the past 3 months compared to the SA market.
Volatility Over Time: Insufficient data to determine 4017's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1978 | 2,672 | Mazen Soliman Abdel Fakeeh | dsfhjeddah.fakeeh.care |
Dr. Soliman Abdel Kader Fakeeh Hospital Company establishes, operates, and manages hospitals, clinics, medical, educational, and training centers in the Kingdom of Saudi Arabia. It offers various services, such as assisted reproductive therapy, audiology, bariatric surgery, breast feeding clinic, cardiac surgery, cardiology, chest and respiratory diseases, chiropractic medicine, dental and maxillofacial, dermatology, otorhinolaryngology, endocrinology, ophthalmology, family medicine, gastroenterology, general surgery, geriatric medicine, hematology, hyperbaric oxygen service, infectious diseases, internal medicine, interventional radiology, psychiatry, nephrology, neuro surgery, neurology, nutrition, obstetrics and gynecology, oncology, orthopedics, pain treatment service, palliative care services, pediatric department, pediatric surgery, physical medicine and rehabilitation, plastic surgery, rheumatology, sleep disorders clinic, speech therapy, thoracic surgery, urology, and vascular surgery. The company also operates AIRS, NICU, endoscopy, the institute of robotic surgery, anesthesia, emergency medicine, intensive care, renal dialysis, rhinoplasty center, and burn units; establishes and manages pharmacies; and laboratory services.
Dr. Soliman Abdel Kader Fakeeh Hospital Company Fundamentals Summary
| 4017 fundamental statistics | |
|---|---|
| Market cap | ر.س13.55b |
| Earnings (TTM) | ر.س287.77m |
| Revenue (TTM) | ر.س2.71b |
47.1x
P/E Ratio5.0x
P/S RatioIs 4017 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4017 income statement (TTM) | |
|---|---|
| Revenue | ر.س2.71b |
| Cost of Revenue | ر.س2.00b |
| Gross Profit | ر.س707.01m |
| Other Expenses | ر.س419.24m |
| Earnings | ر.س287.77m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.25 |
| Gross Margin | 26.08% |
| Net Profit Margin | 10.62% |
| Debt/Equity Ratio | 15.9% |
How did 4017 perform over the long term?
See historical performance and comparison